JavaScript is disabled for your browser. Some features of this site may not work without it.
Statistics
Total Visits
| Views | |
|---|---|
| Treatment characteristics and real-world progression-free survival in patients with unresectable stage III NSCLC who received durvalumab after chemoradiotherapy: Findings from the PACIFIC-R study | 59 |
Total Visits Per Month
| March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | |
|---|---|---|---|---|---|---|---|
| Treatment characteristics and real-world progression-free survival in patients with unresectable stage III NSCLC who received durvalumab after chemoradiotherapy: Findings from the PACIFIC-R study | 2 | 1 | 2 | 5 | 0 | 14 | 3 |
File Visits
| Views | |
|---|---|
| Girard_jto_trea.pdf | 176 |
Top country views
| Views | |
|---|---|
| United States | 47 |
| Japan | 4 |
| Belgium | 2 |
| Spain | 2 |
| Australia | 1 |
| India | 1 |
| Malaysia | 1 |
| Netherlands | 1 |
Top cities views
| Views | |
|---|---|
| Ann Arbor | 6 |
| Boardman | 6 |
| San Ramon | 5 |
| Mountain View | 4 |
| Tokyo | 4 |
| Tustin | 3 |
| Ashburn | 2 |
| Barcelona | 2 |
| Fairfield | 1 |
| Fremont | 1 |
Search DSpace
Browse
My Account
Statistics
